Somatropin (rDNA origin) 5mg/1.5mL, 10mg/1.5mL, 15mg/1.5mL, 30mg/3mL; soln for SC inj. Somatropin binds to dimeric GH receptors located within the cell membranes of target tissue cells. This ...

Novo Nordisk announced that the Food and Drug Administration (FDA) has approved FlexPro PenMate, which is intended for patients who use Norditropin (somatropin [rDNA origin]) FlexPro 5mg, 10mg, and ...

PLAINSBORO, N.J., July 16, 2015 /PRNewswire/ -- Novo Nordisk announced today the U.S. Food and Drug Administration (FDA) approval of FlexPro® PenMate®, designed for users of Norditropin® FlexPro® 5 mg ...

PRINCETON, N.J. The Food and Drug Administration has approved a Novo Nordisk treatment for growth hormone disorders, the Danish drug maker announced Wednesday. The agency approved Norditropin FlexPro ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved somatropin pre-filled injection pens for the treatment of children and adults with growth ...

COPENHAGEN (Reuters) - The PenMate injection device for use with Novo Nordisk's Norditropin Flexpro treatment for growth hormone-related disorders has been approved by the U.S. Food and Drug ...

Norditropin's injection pen slides inside the new FlexPro PenMate so that its needle is hidden during the injection.--Courtesy of Novo Nordisk Novo Nordisk ($NVO ...

Novo Nordisk ((NVO)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Norditropin® FlexPro® is a dial-a-dose pen containing the active ...

COPENHAGEN, July 16 (Reuters) - The PenMate injection device for use with Novo Nordisk's Norditropin Flexpro treatment for growth hormone-related disorders has been approved by the U.S. Food and Drug ...